When to monitor CD4 cell count and HIV RNA to reduce mortality and aids-defining illness in virologically suppressed hiv-positive persons on antiretroviral therapy in high-income countries: A prospective observational study

Ellen C. Caniglia, Caroline Sabin, James M. Robins, Roger Logan, Lauren E. Cain, Sophie Abgrall, Michael J. Mugavero, Sonia Hernandez-DIaz, Laurence Meyer, Remonie Seng, Daniel R. Drozd, George R. Seage, Fabrice Bonnet, Francois Dabis, Richard R. Moore, Peter Reiss, Ard Van Sighem, William C. Mathews, Julia Del Amo, Santiago MorenoSteven G. Deeks, Roberto Muga, Stephen L. Boswell, Elena Ferrer, Joseph J. Eron, Sonia Napravnik, Sophie Jose, Andrew Phillips, Ashley Olson, Amy C. Justice, Janet P. Tate, Heiner C. Bucher, Matthias Egger, Giota Touloumi, Jonathan A. Sterne, Dominique Costagliola, Michael Saag, Miguel A. Hernán

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'When to monitor CD4 cell count and HIV RNA to reduce mortality and aids-defining illness in virologically suppressed hiv-positive persons on antiretroviral therapy in high-income countries: A prospective observational study'. Together they form a unique fingerprint.

Medicine & Life Sciences